| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5703529 | Archivos de la Sociedad Española de Oftalmología | 2017 | 5 Pages |
Abstract
In our experience it seems that the intravitreal ranibizumab in diabetic macular oedema could be a safe alternative in patients with a history of stroke and myocardial infarction.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
R. DÃaz-RodrÃguez, R. Abreu-González, R. Dolz-Marco, R. Gallego-Pinazo,